A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

A systematic review of the diagnostic test accuracy of brief cognitive tests to detect amnestic mild cognitive impairment

(2016) Seline Ozer et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

Dementia in western Europe: epidemiological evidence and implications for policy making

(2016) Yu-Tzu Wu et al.   LANCET NEUROLOGY

Mini Mental State Examination and Logical Memory scores for entry into Alzheimer’s disease trials

(2016) Kimberly R. Chapman et al.   Alzheimers Research & Therapy

Empirically Derived Trajectories to Dementia Over 15 Years of Follow-up Identified by Using Mixed Membership Models

(2015) Fabrizio Lecci et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Attitudes to Alzheimer's disease testing of Australian general practice patients: a cross-sectional questionnaire-based study

(2015) Parker Magin et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Measurement of Longitudinal  -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios

(2015) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Improved Power for Characterizing Longitudinal Amyloid-  PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region

(2015) K. Chen et al.   JOURNAL OF NUCLEAR MEDICINE

Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence

(2015) Adam M. Brickman et al.   NEUROBIOLOGY OF AGING

Physical activity, body mass index, and brain atrophy in Alzheimer's disease

(2015) Christina P. Boyle et al.   NEUROBIOLOGY OF AGING

Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort

(2015) Michael I. Miller et al.   NEUROBIOLOGY OF AGING

Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing

(2015) Robert H. Pietrzak et al.   NEUROBIOLOGY OF AGING

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

(2015) L. G. Apostolova et al.   NEUROLOGY

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease

(2015) Jon B. Toledo et al.   JAMA Neurology

Amyloid-β, Anxiety, and Cognitive Decline in Preclinical Alzheimer Disease

(2015) Robert H. Pietrzak et al.   JAMA Psychiatry

Development of the CHARIOT Research Register for the Prevention of Alzheimer’s Dementia and Other Late Onset Neurodegenerative Diseases

(2015) Mark E. Larsen et al.   PLoS One

CSF Apo-E levels associate with cognitive decline and MRI changes

(2014) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

Extension and refinement of the predictive value of different classes of markers in ADNI: Four-year follow-up data

(2014) Jesus J. Gomar et al.   Alzheimers & Dementia

APOE ε4 and risk for Alzheimer's disease: Do regionally distributed white matter hyperintensities play a role?

(2014) Adam M. Brickman et al.   Alzheimers & Dementia

Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease

(2014) Hiroko H. Dodge et al.   Alzheimers & Dementia

Time course of brain volume changes in the preclinical phase of Alzheimer's disease

(2014) Charlotte Bernard et al.   Alzheimers & Dementia

Sex modifies theAPOE-related risk of developing Alzheimer disease

(2014) Andre Altmann et al.   ANNALS OF NEUROLOGY

Phosphorylated Tau-Aβ 42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid

(2014) Oscar Harari et al.   BIOLOGICAL PSYCHIATRY

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

(2014) Niklas Mattsson et al.   BRAIN

Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting

(2014) Xiaoying Tang et al.   HUMAN BRAIN MAPPING

Analysis of spatio-temporal brain imaging patterns by hidden markov models and serial MRI images

(2014) Ying Wang et al.   HUMAN BRAIN MAPPING

An increased neutrophil–lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation

(2014) Alan Rembach et al.   JOURNAL OF NEUROIMMUNOLOGY

Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease

(2014) Arash Nazeri et al.   NEUROIMAGE

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy

(2014) A. J. Westwood et al.   NEUROLOGY

Clinical trial of an inhibitor of RAGE-A  interactions in Alzheimer disease

(2014) D. Galasko et al.   NEUROLOGY

A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease

(2014) David J. M. McGhee et al.   PLoS One

Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: Effect of different processing and analysis approaches on sample sizes

(2014) Stefan J. Teipel et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Brain region’s relative proximity as marker for Alzheimer’s disease based on structural MRI

(2014) Lene Lillemark et al.   BMC MEDICAL IMAGING

Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness

(2014) A.V. Lebedev et al.   NeuroImage-Clinical

Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease

(2014) Laurent Younes et al.   NeuroImage-Clinical

Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

(2013) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

Effect of Cognitive Reserve Markers on Alzheimer Pathologic Progression

(2013) Raymond Y. Lo et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

The global prevalence of dementia: A systematic review and metaanalysis

(2013) Martin Prince et al.   Alzheimers & Dementia

Focal hemosiderin deposits and β-amyloid load in the ADNI cohort

(2013) Kejal Kantarci et al.   Alzheimers & Dementia

APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease

(2013) Yu-Ling Chang et al.   Alzheimers & Dementia

The future of blood-based biomarkers for Alzheimer's disease

(2013) Kim Henriksen et al.   Alzheimers & Dementia

Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study

(2013) Andrea Chincarini et al.   Alzheimers & Dementia

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

(2013) Alan Rembach et al.   Alzheimers & Dementia

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

(2013) Susan M. Landau et al.   ANNALS OF NEUROLOGY

Reliability of the Alzheimer’s Disease Assessment Scale (ADAS-Cog) in longitudinal Studies

(2013) Anzalee Khan et al.   Current Alzheimer Research

Corpus Callosum Atrophy and Cognitive Decline in Early Alzheimer's Disease: Longitudinal MRI Study

(2013) Minwei Zhu et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

(2013) Kathryn A. Ellis et al.   INTERNATIONAL PSYCHOGERIATRICS

Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study

(2013) Ana Verdelho et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study

(2013) S C Burnham et al.   MOLECULAR PSYCHIATRY

Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease

(2013) Anja Soldan et al.   NEUROBIOLOGY OF AGING

The apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging

(2013) Florence F. Roussotte et al.   NEUROBIOLOGY OF AGING

Neuropathologic basis of white matter hyperintensity accumulation with advanced age

(2013) D. Erten-Lyons et al.   NEUROLOGY

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

(2013) C. R. Jack et al.   NEUROLOGY

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: Rates and acceleration

(2013) K. K. Leung et al.   NEUROLOGY

Evaluating Alzheimer’s Disease Progression Using Rate of Regional Hippocampal Atrophy

(2013) Edit Frankó et al.   PLoS One

Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment

(2013) Gwenaëlle Douaud et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

(2013) T. L. S. Benzinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Brain Imaging and Cognitive Predictors of Stroke and Alzheimer Disease in the Framingham Heart Study

(2013) Galit Weinstein et al.   STROKE

Dissociable Effects of Alzheimer Disease and White Matter Hyperintensities on Brain Metabolism

(2013) Thaddeus J. Haight   JAMA Neurology

Cross-sectional and Longitudinal Analysis of the Relationship Between Aβ Deposition, Cortical Thickness, and Memory in Cognitively Unimpaired Individuals and in Alzheimer Disease

(2013) Vincent Doré et al.   JAMA Neurology

Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly Persons With β-Amyloidosis

(2013) David S. Knopman et al.   JAMA Neurology

Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

(2013) Xiao Da et al.   NeuroImage-Clinical

Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults

(2012) Donata Paternicò et al.   Alzheimers & Dementia

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study

(2012) Wesley Jongbloed et al.   Alzheimers & Dementia

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

(2012) Nandini Raghavan et al.   Alzheimers & Dementia

Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease

(2012) Paula T. Trzepacz et al.   Alzheimers & Dementia

Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease

(2012) Milap A. Nowrangi et al.   Alzheimers & Dementia

Brain size and the compensation of Alzheimer's disease symptoms: A longitudinal cohort study

(2012) Liang-Hao Guo et al.   Alzheimers & Dementia

Relative contributions of biomarkers in Alzheimer’s disease

(2012) Thaddeus J. Haight et al.   ANNALS OF EPIDEMIOLOGY

Comparison of Imaging Biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging

(2012) Jennifer L. Whitwell   ARCHIVES OF NEUROLOGY

Depressive Symptoms in Mild Cognitive Impairment Predict Greater Atrophy in Alzheimer's Disease-Related Regions

(2012) Grace J. Lee et al.   BIOLOGICAL PSYCHIATRY

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study

(2012) Nicolas Villain et al.   BRAIN

Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer’s Disease and Mild Cognitive Impairment

(2012) Eric Westman et al.   BRAIN TOPOGRAPHY

Accelerating Cortical Thinning: Unique to Dementia or Universal in Aging?

(2012) Anders M. Fjell et al.   CEREBRAL CORTEX

Evolution of Global and Local Grey Matter Atrophy on Serial MRI Scans During the Progression from MCI to AD

(2012) Gabriela Spulber et al.   Current Alzheimer Research

Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns

(2012) Chong-Yaw Wee et al.   HUMAN BRAIN MAPPING

Improved prediction of Alzheimer's disease with longitudinal white matter/gray matter contrast changes

(2012) Håkon Grydeland et al.   HUMAN BRAIN MAPPING

Loss of Intranetwork and Internetwork Resting State Functional Connections with Alzheimer's Disease Progression

(2012) M. R. Brier et al.   JOURNAL OF NEUROSCIENCE

A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort

(2012) Bruno M. Jedynak et al.   NEUROIMAGE

Coevolution of brain structures in amnestic mild cognitive impairment

(2012) Owen Carmichael et al.   NEUROIMAGE

MIRIAD—Public release of a multiple time point Alzheimer's MR imaging dataset

(2012) Ian B. Malone et al.   NEUROIMAGE

Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models

(2012) Jorge L. Bernal-Rusiel et al.   NEUROIMAGE

Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults

(2012) O. C. Okonkwo et al.   NEUROLOGY

Predicting missing biomarker data in a longitudinal study of Alzheimer disease

(2012) R. Y. Lo et al.   NEUROLOGY

Vascular burden and Alzheimer disease pathologic progression

(2012) R. Y. Lo et al.   NEUROLOGY

Coevolution of white matter hyperintensities and cognition in the elderly

(2012) P. Maillard et al.   NEUROLOGY

Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers

(2012) Daoqiang Zhang et al.   PLoS One

Non-Stationarity in the “Resting Brain’s” Modular Architecture

(2012) David T. Jones et al.   PLoS One

Rates of Decline in Alzheimer Disease Decrease with Age

(2012) Dominic Holland et al.   PLoS One

Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers

(2012) Jennifer L. Shaffer et al.   RADIOLOGY

Physical Activity Prevents Progression for Cognitive Impairment and Vascular Dementia

(2012) Ana Verdelho et al.   STROKE

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

(2011) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data

(2011) Andrei G. Vlassenko et al.   ANNALS OF NEUROLOGY

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

(2011) Victor L. Villemagne et al.   ANNALS OF NEUROLOGY

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

(2011) Clifford R. Jack et al.   ANNALS OF NEUROLOGY

Longitudinal Change of Biomarkers in Cognitive Decline

(2011) Raymond Y. Lo   ARCHIVES OF NEUROLOGY

Evidence for Ordering of Alzheimer Disease Biomarkers

(2011) Clifford R. Jack   ARCHIVES OF NEUROLOGY

Empirical derivation of the reference region for computing diagnostic sensitive 18fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample

(2011) Jerod M. Rasmussen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging

(2011) Jeffrey M. Burns et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Midlife obesity and trajectories of brain volume changes in older adults

(2011) Ira Driscoll et al.   HUMAN BRAIN MAPPING

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

(2011) Heiko Braak et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Apolipoprotein Epsilon 4 Allele Modifies Waist-to-Hip Ratio Effects on Cognition and Brain Structure

(2011) David Zade et al.   Journal of Stroke & Cerebrovascular Diseases

Sex differences in grey matter atrophy patterns among AD and aMCI patients: Results from ADNI

(2011) Martha Skup et al.   NEUROIMAGE

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

(2011) S. Salloway et al.   NEUROLOGY

Mild Cognitive Impairment: Baseline and Longitudinal Structural MR Imaging Measures Improve Predictive Prognosis

(2011) Linda K. McEvoy et al.   RADIOLOGY

Identifying Cognitively Healthy Elderly Individuals with Subsequent Memory Decline by Using Automated MR Temporoparietal Volumes

(2011) Gloria C. Chiang et al.   RADIOLOGY

Testing the Right Target and Right Drug at the Right Stage

(2011) R. A. Sperling et al.   Science Translational Medicine

Longitudinal Rates of Lobar Atrophy in Frontotemporal Dementia, Semantic Dementia, and Alzheimerʼs Disease

(2010) Casey E. Krueger et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Japanese Alzheimer's Disease Neuroimaging Initiative: Present status and future

(2010) Takeshi Iwatsubo   Alzheimers & Dementia

The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes

(2010) Laurel A. Beckett et al.   Alzheimers & Dementia

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

(2010) William J. Jagust et al.   Alzheimers & Dementia

Donepezil Treatment and Changes in Hippocampal Structure in Very Mild Alzheimer Disease

(2010) Lei Wang et al.   ARCHIVES OF NEUROLOGY

Larger temporal volume in elderly with high versus low beta-amyloid deposition

(2010) Gaël Chételat et al.   BRAIN

Cardiac Index Is Associated With Brain Aging

(2010) Angela L. Jefferson et al.   CIRCULATION

3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI

(2010) Liana G. Apostolova et al.   HUMAN BRAIN MAPPING

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease : experience from the first 24 months

(2010) Andrew Simmons et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Plasma A 42 and A 40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

(2010) T. T. Seppala et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

(2010) S. J. Cano et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease

(2010) A. M. Fjell et al.   JOURNAL OF NEUROSCIENCE

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

(2010) Lars M. Ittner et al.   NATURE REVIEWS NEUROSCIENCE

Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort

(2010) Shannon L. Risacher et al.   NEUROBIOLOGY OF AGING

Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans

(2010) Xue Hua et al.   NEUROBIOLOGY OF AGING

Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline

(2010) J. Nettiksimmons et al.   NEUROBIOLOGY OF AGING

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification

(2010) Christos Davatzikos et al.   NEUROBIOLOGY OF AGING

Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI

(2010) Robin Wolz et al.   NEUROIMAGE

Determining the optimal level of smoothing in cortical thickness analysis: A hierarchical approach based on sequential statistical thresholding

(2010) Jorge L. Bernal-Rusiel et al.   NEUROIMAGE

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

(2010) Kewei Chen et al.   NEUROIMAGE

High-dimensional pattern regression using machine learning: From medical images to continuous clinical variables

(2010) Ying Wang et al.   NEUROIMAGE

Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals

(2010) Xue Hua et al.   NEUROIMAGE

Gray matter concentration and effective connectivity changes in Alzheimer’s disease: a longitudinal structural MRI study

(2010) Xingfeng Li et al.   NEURORADIOLOGY

Apolipoprotein E and Gray Matter Volume Loss in Patients with Mild Cognitive Impairment and Alzheimer Disease

(2010) Maria Vittoria Spampinato et al.   RADIOLOGY

Role of structural MRI in Alzheimer's disease

(2010) Prashanthi Vemuri et al.   Alzheimers Research & Therapy

Midlife and Late-Life Obesity and the Risk of Dementia

(2009) Annette L. Fitzpatrick et al.   ARCHIVES OF NEUROLOGY

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

(2009) C. Davatzikos et al.   BRAIN

Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment

(2009) Maria Bjerke et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

One-Year Brain Atrophy Evident in Healthy Aging

(2009) A. M. Fjell et al.   JOURNAL OF NEUROSCIENCE

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Alzheimer's Disease Neuroimaging Initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

(2009) Alex D. Leow et al.   NEUROIMAGE

Comparison of phantom and registration scaling corrections using the ADNI cohort

(2009) Matthew J. Clarkson et al.   NEUROIMAGE

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects

(2009) Xue Hua et al.   NEUROIMAGE

Longitudinal pattern of regional brain volume change differentiates normal aging from MCI

(2009) I. Driscoll et al.   NEUROLOGY

Association of parental dementia with cognitive and brain MRI measures in middle-aged adults

(2009) S. Debette et al.   NEUROLOGY

Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease

(2009) Peder Buchhave et al.   PLoS One

Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment

(2009) Pei-Ning Wang et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men

(2008) Johan Sundelöf et al.   ARCHIVES OF NEUROLOGY

Volumetric MRI and cognitive measures in Alzheimer disease

(2008) B. H. Ridha et al.   JOURNAL OF NEUROLOGY

Endpoints for trials in Alzheimer's disease: a European task force consensus

(2008) Bruno Vellas et al.   LANCET NEUROLOGY

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study

(2008) Jasper D. Sluimer et al.   NEUROBIOLOGY OF AGING

Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls

(2008) Jonathan H. Morra et al.   NEUROIMAGE

Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI☆

(2008) C MISRA et al.   NEUROIMAGE

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

(2008) O. L. Lopez et al.   NEUROLOGY